BMRN BioMarin Pharmaceutical Inc
BioMarin Pharmaceutical Inc price
3.00% Past Week
Market Cap
13.39B
Day’s Range
52W Range
Volume (3M)
1.74M
Price-Earnings Ratio
53.11
Revenue
2.59B
BioMarin Pharmaceutical Inc Latest News
Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
50
Medium
Industry
Avg. 43
39
Environment
55
Social
45
Governance
Business Involvement Flags
GMO
Companies engaged in plant and animal breeding, genetics and genomics, including
animal and plant DNA testing services.
Consensus
Strong Buy
Price Target
106.92
People Also Bought
- SNDX Syndax Pharmaceuticals Inc 5.11%
- RAMP LiveRamp Holding 1.03%
- TENB Tenable Holdings Inc -0.75%
- IMVT Immunovant Inc 1.57%
- RCKT Rocket Pharmaceuticals Inc 3.38%